Healthcare & Life Sciences
Octavebio
United Stateswww.octavebio.com/
Octavebio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Octavebio
Octavebio is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Octavebio develops a clinically validated blood test that measures multiple protein biomarkers to assess real-time disease activity in multiple sclerosis, aiding providers and patients in precision neurology care decisions.
Explore Octavebio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.